Initial therapy, persistence and regimen change in a cohort of newly treated type 2 diabetes patients

Cardiovascular outcome trials of glucose-lowering drugs or strategies in type 2 diabetes

(2014) Rury R Holman et al.   LANCET

Diabetes as a risk factor for stroke in women compared with men: a systematic review and meta-analysis of 64 cohorts, including 775 385 individuals and 12 539 strokes

(2014) Sanne A E Peters et al.   LANCET

An observational study examining the effect of comorbidity on the rates of persistence and adherence to newly initiated oral anti-hyperglycaemic agents

(2013) Miriam P. O'Shea et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Patterns of Medication Initiation in Newly Diagnosed Diabetes Mellitus: Quality and Cost Implications

(2012) Nihar R. Desai et al.   AMERICAN JOURNAL OF MEDICINE

Glycemic Control and Cardiovascular Disease: What’s a Doctor to Do?

(2012) Preeti Kishore et al.   Current Diabetes Reports

Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach: Position Statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

(2012) S. E. Inzucchi et al.   DIABETES CARE

Diabetes and cognitive dysfunction

(2012) Rory J McCrimmon et al.   LANCET

Initial and subsequent therapy for newly diagnosed type 2 diabetes patients treated in primary care using data from a vendor-based electronic health record

(2012) Emily S. Brouwer et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Trends in drug prescriptions to diabetic patients from 2000 to 2008 in Italy's Lombardy Region: A large population-based study

(2011) Marta Baviera et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

Long term patterns of use after initiation of oral antidiabetic drug therapy

(2010) Egbert J. F. Lamberts et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Persistence Patterns with Oral Antidiabetes Drug Treatment in Newly Treated Patients—A Population-Based Study

(2010) Jean-Pierre Grégoire et al.   VALUE IN HEALTH

Many Americans Have Pre-Diabetes and Should Be Considered for Metformin Therapy

(2009) M. K. Rhee et al.   DIABETES CARE

Trends in the prescription of anti-diabetic medications in the United Kingdom: a population-based analysis

(2009) Kristian B. Filion et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Effect of non-persistent use of oral glucose-lowering drugs on HbA1cgoal attainment

(2008) Fernie J. A. Penning-van Beest et al.   CURRENT MEDICAL RESEARCH AND OPINION

Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy: A consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes

(2008) D. M. Nathan et al.   DIABETES CARE

Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes

(2008)   NEW ENGLAND JOURNAL OF MEDICINE

Effects of Intensive Glucose Lowering in Type 2 Diabetes

(2008)   NEW ENGLAND JOURNAL OF MEDICINE

Glucose Control and Vascular Complications in Veterans with Type 2 Diabetes

(2008) William Duckworth et al.   NEW ENGLAND JOURNAL OF MEDICINE

Prevalence and antihyperglycemic prescribing trends for patients with type 2 diabetes in Italy: A 4-year retrospective study from national primary care data

(2008) Giampiero Mazzaglia et al.   PHARMACOLOGICAL RESEARCH